Bio-Rad Laboratories (NYSE:BIO) reported its Q2 earnings results on Thursday, July 28, 2022 at 04:00 PM.
Here’s what investors need to know about the announcement.
Earnings
Bio-Rad Laboratories beat estimated earnings by 20.71%, reporting an EPS of $3.38 versus an estimate of $2.8.
Revenue was down $24.83 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $1.54 which was followed by a 0.2% drop in the share price the next day.
Here’s a look at Bio-Rad Laboratories’s past performance:
| Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|
| EPS Estimate | 3.40 | 2.85 | 2.44 | 2.66 |
| EPS Actual | 4.94 | 3.21 | 3.71 | 3.54 |
| Revenue Estimate | 675.10M | 731.98M | 661.87M | 631.78M |
| Revenue Actual | 700.06M | 732.77M | 715.20M | 715.93M |
To track all earnings releases for Bio-Rad Laboratories visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
